MicroRNAs and DNA-Damaging Drugs in Breast Cancer: Strength in Numbers
MicroRNAs are a class of small non-coding regulatory RNAs playing key roles in cancer. Breast cancer is the most common female malignancy worldwide and is categorized into four molecular subtypes: luminal A and B, HER2+ and triple-negative breast cancer (TNBC). Despite the development of multiple ta...
Main Authors: | Ilaria Plantamura, Giulia Cosentino, Alessandra Cataldo |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-09-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2018.00352/full |
Similar Items
-
MicroRNAs, DNA Damage Response, and Cancer Treatment
by: Mingyang He, et al.
Published: (2016-12-01) -
Editorial: MicroRNA Signatures in Plant Genome Stability and Genotoxic Stress
by: Anca Macovei, et al.
Published: (2021-04-01) -
Tiny Yet Indispensable Plant MicroRNAs Are Worth to Explore as Key Components for Combating Genotoxic Stresses
by: Moumita Roy Chowdhury, et al.
Published: (2019-10-01) -
DNA Damage and Repair in Atherosclerosis: Current Insights and Future Perspectives
by: Maria Grazia Andreassi, et al.
Published: (2012-12-01) -
The multifaceted world of the DNA damage response
by: Antonio ePorro
Published: (2016-05-01)